We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

193 hedge funds and large institutions have $2.8B invested in NEVRO CORP. in 2017 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 68 increasing their positions, 64 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 18

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

31% more capital invested

Capital invested by funds: $2.14B → $2.8B (+$659M)

13% more call options, than puts

Call options by funds: $12.6M | Put options by funds: $11.2M

11% more funds holding

Funds holding: 174193 (+19)

6% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 64

Holders
193
Holders Change
+19
Holders Change %
+10.92%
% of All Funds
4.78%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.12%
New
44
Increased
68
Reduced
64
Closed
18
Calls
$12.6M
Puts
$11.2M
Net Calls
+$1.4M
Net Calls Change
-$7.24M

NVRO Hedge Fund Activity: Q1 2017 in Review

193 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q1 2017, worth a combined $2.8B — up 31% from $2.14B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new NVRO positions and 18 closed out — a net gain of 26 holders — while 68 added to existing stakes and 64 trimmed.

The largest buyer was BlackRock, adding an estimated $143M. The largest seller was Fidelity Investments, cutting an estimated $44.6M.

  • 193 institutional investors held NEVRO CORP. (NVRO) as of Q1 2017, up from 174 in Q4 2016.
  • Funds reported $2.8B of NEVRO CORP. stock for Q1 2017, up 31% quarter-over-quarter.
  • 44 funds opened new NEVRO CORP. positions in Q1 2017 and 18 closed out, a net change of +26 holders.
  • The largest NEVRO CORP. buyer in Q1 2017 was BlackRock, an estimated $143M added.
  • The largest NEVRO CORP. seller in Q1 2017 was Fidelity Investments, an estimated $44.6M sold.

Based on aggregated 13F filings for Q1 2017.